Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baird Maintains Outperform on Equifax, Raises Price Target to $223

Baird Maintains Outperform on Equifax, Raises Price Target to $223

Baird analyst Jeffrey Meuler maintains Equifax (NYSE:EFX) with a Outperform and raises the price target from $199 to $223.

byBenzinga Newsdesk

November 25, 2022

1 minute read

Baird analyst Jeffrey Meuler maintains Equifax (NYSE:EFX) with a Outperform and raises the price target from $199 to $223.

After Collapsing Terraform Labs, CEO Do Kwon Is On The Lam — In Serbia: Report

By Murtuza Merchant

December 12, 10:14 AM

Terraform Labs co-founder and CEO Do Kwon, wanted internationally in relation to the collapse of the Terra ecosystem, has traveled from Dubai to Serbia, where he is currently hiding.

LUNA

Guggenheim Downgrades Teladoc Health to Sell, Announces $25 Price Target

By Benzinga Newsdesk

August 17, 7:06 AM

Guggenheim analyst Sandy Draper downgrades Teladoc Health (NYSE:TDOC) from Neutral to Sell and announces $25 price target.

TDOC

Cosmetics Company Estee Lauder Is Sliding Friday Morning – Here’s Why

By Shivani Kumaresan

August 18, 8:16 AM

Estee Lauder Companies Inc (NYSE: EL) shares are down Friday morning following its fourth quarter results and lackluster outlook.

News

What’s Going On With Disney Stock?

By Henry Khederian

November 13, 3:24 PM

Walt Disney Co (NYSE: DIS) shares are trading higher by 1.5% to $89.60 Monday afternoon.

DIS

Baird Maintains Outperform on Equifax, Raises Price Target to $223

Related Posts

After Collapsing Terraform Labs, CEO Do Kwon Is On The Lam — In Serbia: Report

Guggenheim Downgrades Teladoc Health to Sell, Announces $25 Price Target

Cosmetics Company Estee Lauder Is Sliding Friday Morning – Here’s Why

What’s Going On With Disney Stock?